Skip to content

Psychedelic compounds directly excite 5-HT 2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT 2A Gq -mediated activation mechanism

Gavin P. Schmitz, Yi-Ting Chiu, Gabriele M. König, Evi Kostenis, Bryan L. Roth, Melissa A. Herman

bioRxiv (Cold Spring Harbor Laboratory) November 15, 2022 preprint DOI: 10.1101/2022.11.15.516655 via OpenAlex

Summary

AI-generated from the abstract

Psilocin, the active compound in psilocybin mushrooms, activates serotonin 2A receptors (5-HT2ARs) in the prefrontal cortex (PFC), but its specific effects on PFC neurons were unclear. Using slice electrophysiology in mice, researchers found that psilocin application onto layer 5 pyramidal neurons in the prelimbic PFC produced variable firing changes (increase, decrease, or no change) in unspecific neurons. However, in neurons identified as expressing 5-HT2ARs, psilocin consistently increased firing without altering synaptic transmission. The results demonstrate that psilocin evokes strong, 5-HT2AR- and Gαq-dependent firing changes in the PFC, offering insights into how psychedelics affect a brain region key to their therapeutic actions.

Study at a glance

Characteristics In vitro electrophysiology study
Population Layer 5 pyramidal neurons in the prelimbic prefrontal cortex of C57BL/6J mice (including 5-HT2A-ERT2-Cre crossed with Ai9 tdTomato reporter mice)
Intervention psilocin
Dose 10 μM
Topics Serotonin
Keywords Infralimbic cortex Prefrontal cortex Neuroscience 5-HT Receptor
Citations 15
Key finding Psilocin increases firing in identified 5-HT2A receptor-expressing layer 5 pyramidal neurons in the mouse prelimbic prefrontal cortex, an effect dependent on 5-HT2A receptors and Gαq signaling.

Abstract

Summary Psilocin, the active compound in Psilocybe sp . mushrooms, is a serotonergic psychedelic that has recently gained renewed interest due to its potential as a therapeutic tool. Despite promising clinical findings, the underlying signaling mechanisms and brain region-specific effects of psilocin and other psychedelic drugs remain unclear. Psilocin, like other psychedelic compounds, is an agonist at many serotonin and other biogenic amine receptors; however, activation of serotonin (5-Hydroxytryptamine, or 5-HT) 2A receptors (5-HT 2A Rs) is understood as the main molecular target for the psychoactive effects in animals and humans. 5-HT 2A Rs are abundantly expressed in the prefrontal cortex (PFC); however, the biochemical actions of psilocin on PFC neurons remain poorly understood. In this study, we used in vitro slice electrophysiology to examine how psilocin acutely alters the activity and electrophysiological properties of layer 5 pyramidal neurons in the mouse PFC. Focal application of psilocin (10 μ M) onto nonspecified Layer 5 Pyramidal neurons in the prelimbic PFC of C57BL/6J mice produced variable effects on firing (increase, decrease, or no change). 5-HT 2A R layer 5 pyramidal neurons in the mouse prelimbic PFC were identified via labeling in a 5-HT2A-ERT2-Cre mouse crossed with an Ai9 tdTomato reporter. Focal application of psilocin increased firing in all identified 5-HT 2A R neurons but did not result in any significant changes in synaptic transmission. Overall, the results demonstrate that psilocin evokes strong firing changes in the PFC that are 5-HT 2A R and G α q dependent, thereby providing valuable insights into the effects of psilocin on a brain region implicated in mediating psychedelic drug actions.

Explore topics

Comments

No comments yet.

Log in to comment